Large-cell transformation is an independent poor prognostic factor in Sézary syndrome: analysis of 117 cases

Br J Dermatol. 2022 Nov;187(5):815-817. doi: 10.1111/bjd.21738. Epub 2022 Aug 2.

Authors

Christophe Bontoux^{1

2

3}, Adèle de Masson^{4

2

3}, Nicolas Thonnart^{2

3}, Caroline Ram-Wolff^{4

2

3}, Flavien Caraguel⁵, Luciana Batista⁵, Sabrina Carpentier⁵, Hélène Moins-Teisserenc^{3

6

7}, Jacqueline Rivet¹, Marie-Dominique Vignon-Pennamen¹, Anne Marie-Cardine^{2

3}, Martine Bagot^{4

2

3}, Maxime Battistella^{1

2

3}

Affiliations

¹ Department of Pathology, Hôpital Saint-Louis, AP-HP, Paris, France.
² INSERM U976, HIPI, Paris, France.
³ Université de Paris, Institut de Recherche Saint-Louis, Paris, France.
⁴ Department of Dermatology, Hôpital Saint-Louis, AP-HP, Paris, France.
⁵ Innate Pharma, Marseille, France.
⁶ Clinical Haematology Laboratory, Hôpital Saint-Louis, AP-HP, Paris, France.
⁷ INSERM U1160, Paris, France.

No abstract available

Publication types

Letter

MeSH terms

Cell Transformation, Neoplastic
Humans
Mycosis Fungoides*
Prognosis
Sezary Syndrome*
Skin Neoplasms*